OPTIMER PHARMACEUTICALS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2008. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2008-03-12: Reporting owner Gorbach MD Sherwood; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-01-24: Reporting owner Gorbach MD Sherwood; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2008-01-24: Reporting owner Gorbach MD Sherwood; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2008-01-24: Reporting owner Gorbach MD Sherwood; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2008-03-12 | Gorbach MD Sherwood Officer (Senior VP & Chief Med. Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $6.60 exercise price | 2008-03-13 | |
| 2008-01-24 | Gorbach MD Sherwood Officer (Senior VP, Chief Med. Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,851 11,610 owned after | $1.08 exercise price | 2008-01-25 | |
| 2008-01-24 | Gorbach MD Sherwood Officer (Senior VP, Chief Med. Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,731 1,298 owned after | $1.08 exercise price | 2008-01-25 | |
| 2008-01-24 | Gorbach MD Sherwood Officer (Senior VP, Chief Med. Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,730 0 owned after | $1.08 exercise price | 2008-01-25 | |
| 2008-01-04 | Gorbach MD Sherwood Officer (SVP & Chief Medical Affairs) | 4 | Stock Option - right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $6.90 exercise price | 2008-01-07 | |
| 2008-01-04 | Shue Youe Kong Officer (VP, Clinical Development) | 4 | Stock Option - right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $6.90 exercise price | 2008-01-07 | |
| 2008-01-04 | Poulos Kevin P Officer (Chief Commercial Officer) | 4 | Stock Option - right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $6.90 exercise price | 2008-01-07 | |
| 2008-01-04 | Che Tessie M Officer (Chief Operating Office and SVP) | 4 | Stock Option - right to buy Derivative · Direct · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $6.90 exercise price | 2008-01-07 | |
| 2008-01-04 | Che Tessie M Officer (Chief Operating Office and SVP) | 4 | Stock Option - right to buy Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $6.90 exercise price | 2008-01-07 | |
| 2008-01-04 | Prunty John D Officer (CFO) | 4 | Stock Option - right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $6.90 exercise price | 2008-01-07 | |
| 2008-01-04 | Chang Michael N Director, Officer (President and CEO) | 4 | Stock Option - right to buy Derivative · Direct · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $6.90 exercise price | 2008-01-07 | |
| 2008-01-04 | Chang Michael N Director, Officer (President and CEO) | 4 | Stock Option -right to buy Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $6.90 exercise price | 2008-01-07 |